BMX Represses Thrombin-PAR1–Mediated Endothelial Permeability and Vascular Leakage During Early Sepsis
- 14 February 2020
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 126 (4) , 471-485
Abstract
Rationale: BMX (bone marrow kinase on the X chromosome) is highly expressed in the arterial endothelium from the embryonic stage to the adult stage in mice. It is also expressed in microvessels and the lymphatics in response to pathological stimuli. However, its role in endothelial permeability and sepsis remains unknown. Objective: We aimed to delineate the function of BMX in thrombin-mediated endothelial permeability and the vascular leakage that occurs with sepsis in cecal ligation and puncture models. Methods and Results: The cecal ligation and puncture model was applied to WT (wild type) and BMX-KO (BMX global knockout) mice to induce sepsis. Meanwhile, the electric cell-substrate impedance sensing assay was used to detect transendothelial electrical resistance in vitro and, the modified Miles assay was used to evaluate vascular leakage in vivo. We showed that BMX loss caused lung injury and inflammation in early cecal ligation and puncture–induced sepsis. Disruption of BMX increased thrombin-mediated permeability in mice and cultured endothelial cells by 2- to 3-fold. The expression of BMX in macrophages, neutrophils, platelets, and lung epithelial cells was undetectable compared with that in endothelial cells, indicating that endothelium dysfunction, rather than leukocyte and platelet dysfunction, was involved in vascular permeability and sepsis. Mechanistically, biochemical and cellular analyses demonstrated that BMX specifically repressed thrombin-PAR1 (protease-activated receptor-1) signaling in endothelial cells by directly phosphorylating PAR1 and promoting its internalization and deactivation. Importantly, pretreatment with the selective PAR1 antagonist SCH79797 rescued BMX loss-mediated endothelial permeability and pulmonary leakage in early cecal ligation and puncture–induced sepsis. Conclusions: Acting as a negative regulator of PAR1, BMX promotes PAR1 internalization and signal inactivation through PAR1 phosphorylation. Moreover, BMX-mediated PAR1 internalization attenuates endothelial permeability to protect vascular leakage during early sepsis.Keywords
This publication has 63 references indexed in Scilit:
- Endothelial epsin deficiency decreases tumor growth by enhancing VEGF signalingJournal of Clinical Investigation, 2012
- Adaptor Protein Complex-2 (AP-2) and Epsin-1 Mediate Protease-activated Receptor-1 Internalization via Phosphorylation- and Ubiquitination-dependent Sorting SignalsJournal of Biological Chemistry, 2011
- Functional Analyses of the Bone Marrow Kinase in the X Chromosome in Vascular Endothelial Growth Factor–Induced LymphangiogenesisArteriosclerosis, Thrombosis, and Vascular Biology, 2010
- Endothelial-Specific Transgenesis of TNFR2 Promotes Adaptive Arteriogenesis and AngiogenesisArteriosclerosis, Thrombosis, and Vascular Biology, 2010
- Opening the flood-gates: how neutrophil-endothelial interactions regulate permeabilityTrends in Immunology, 2009
- Immunodesign of experimental sepsis by cecal ligation and punctureNature Protocols, 2008
- Loss of Bmx Nonreceptor Tyrosine Kinase Prevents Pressure Overload–Induced Cardiac HypertrophyCirculation Research, 2008
- 'Role reversal' for the receptor PAR1 in sepsis-induced vascular damageNature Immunology, 2007
- Proteomic analysis of inflammatory biomarkers in bronchoalveolar lavageProteomics, 2006
- Clathrin Adaptor AP2 Regulates Thrombin Receptor Constitutive Internalization and Endothelial Cell ResensitizationMolecular and Cellular Biology, 2006